ALN-RSV01

· Alnylam Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ALN-RSV01, covering 2007-11-30 to 2018-02-05. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2b Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV) [Phase 2]